Literature DB >> 23126358

The 50th anniversary of the Kefauver-Harris Amendments: efficacy assessment and the randomized clinical trial.

J Rick Turner1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23126358      PMCID: PMC8108842          DOI: 10.1111/jch.12012

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

1.  Illuminating HDL--is it still a viable therapeutic target?

Authors:  Daniel J Rader
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

2.  STREPTOMYCIN treatment of pulmonary tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1948-10-30

Review 3.  New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future.

Authors:  Christian Lienhardt; Mario Raviglione; Mel Spigelman; Richard Hafner; Ernesto Jaramillo; Michael Hoelscher; Alimuddin Zumla; Jan Gheuens
Journal:  J Infect Dis       Date:  2012-03-22       Impact factor: 5.226

4.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

5.  The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program.

Authors: 
Journal:  J Chronic Dis       Date:  1979

Review 6.  Advancing management of hypertension through pharmacogenomics.

Authors:  Julie A Johnson
Journal:  Ann Med       Date:  2012-06       Impact factor: 4.709

7.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

8.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1982-02-05       Impact factor: 56.272

View more
  4 in total

Review 1.  Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.

Authors:  Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle
Journal:  Clin Ther       Date:  2017-01-07       Impact factor: 3.393

2.  Must new drugs be superior to those already available? The role of noninferiority clinical trials.

Authors:  J Rick Turner; Todd A Durham
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-07       Impact factor: 3.738

Review 3.  Clinical trials in new drug development.

Authors:  J Rick Turner; Theo J Hoofwijk
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-03-13       Impact factor: 3.738

4.  Meta-methodology: conducting and reporting meta-analyses.

Authors:  J Rick Turner; Todd A Durham
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.